Clinical trial

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients…

NCT00028756 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00028756
Title Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Official title Randomized Phase III Trial Comparing Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients With pT3-pT4, and/or N+M0 Transitional Cell Carcinoma (TCC) of the Bladder
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Collaborators National Cancer Institute (NCI) NIH Groupe D'Etude des Tumeurs Uro-Genitales Institute of Cancer Research, United Kingdom NCIC Clinical Trials Group Arbeitsgemeinschaft Urologische Onkologie
Status Completed
Phase Phase 3
Study type Interventional
Conditions Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder
Intervention type Biological, Drug
Interventions doxorubicin hydrochloride, gemcitabine hydrochloride, vinblastine sulfate, methotrexate, cisplatin, filgrastim
Enrollment 285
Start date Oct 1, 2001
Primary completion Jan 1, 2014
Completion Jul 1, 2014
First posted Jan 27, 2003
Last update posted Aug 2, 2016

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies